125 related articles for article (PubMed ID: 10374844)
61. Nicotine modulates the effects of retinoids on growth inhibition and RAR beta expression in lung cancer cells.
Chen GQ; Lin B; Dawson MI; Zhang XK
Int J Cancer; 2002 May; 99(2):171-8. PubMed ID: 11979430
[TBL] [Abstract][Full Text] [Related]
62. Comparison of the mechanism of induction of apoptosis in ovarian carcinoma cells by the conformationally restricted synthetic retinoids CD437 and 4-HPR.
Holmes WF; Soprano DR; Soprano KJ
J Cell Biochem; 2003 May; 89(2):262-78. PubMed ID: 12704790
[TBL] [Abstract][Full Text] [Related]
63. Keratins 2 and 4/13 in reconstituted human skin are reciprocally regulated by retinoids binding to nuclear receptor RARalpha.
Virtanen M; Sirsjö A; Vahlquist A; Törmä H
Exp Dermatol; 2010 Jul; 19(7):674-81. PubMed ID: 20456496
[TBL] [Abstract][Full Text] [Related]
64. Structure-based design of Trifarotene (CD5789), a potent and selective RARγ agonist for the treatment of acne.
Thoreau E; Arlabosse JM; Bouix-Peter C; Chambon S; Chantalat L; Daver S; Dumais L; Duvert G; Feret A; Ouvry G; Pascau J; Raffin C; Rodeville N; Soulet C; Tabet S; Talano S; Portal T
Bioorg Med Chem Lett; 2018 Jun; 28(10):1736-1741. PubMed ID: 29706423
[TBL] [Abstract][Full Text] [Related]
65. Potentiation of the teratogenic effects induced by coadministration of retinoic acid or phytanic acid/phytol with synthetic retinoid receptor ligands.
Elmazar MM; Nau H
Arch Toxicol; 2004 Nov; 78(11):660-8. PubMed ID: 15558240
[TBL] [Abstract][Full Text] [Related]
66. Synthetic retinoid CD437 promotes rapid apoptosis in malignant human epidermal keratinocytes and G1 arrest in their normal counterparts.
Hail N; Lotan R
J Cell Physiol; 2001 Jan; 186(1):24-34. PubMed ID: 11147811
[TBL] [Abstract][Full Text] [Related]
67. Antagonists of retinoic acid receptors (RARs) are potent growth inhibitors of prostate carcinoma cells.
Hammond LA; Van Krinks CH; Durham J; Tomkins SE; Burnett RD; Jones EL; Chandraratna RA; Brown G
Br J Cancer; 2001 Aug; 85(3):453-62. PubMed ID: 11487280
[TBL] [Abstract][Full Text] [Related]
68. Synthetic retinoid CD437 induces S-phase arrest and apoptosis in human prostate cancer cells LNCaP and PC-3.
Liang JY; Fontana JA; Rao JN; Ordonez JV; Dawson MI; Shroot B; Wilber JF; Feng P
Prostate; 1999 Feb; 38(3):228-36. PubMed ID: 10068347
[TBL] [Abstract][Full Text] [Related]
69. Both retinoic acid receptors alpha (RARalpha) and gamma (RARgamma) are able to initiate mouse upper-lip skin glandular metaplasia.
Blanchet S; Favier B; Chevalier G; Kastner P; Michaille JJ; Chambon P; Dhouailly D
J Invest Dermatol; 1998 Aug; 111(2):206-12. PubMed ID: 9699718
[TBL] [Abstract][Full Text] [Related]
70. Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cells.
Zang Y; Beard RL; Chandraratna RA; Kang JX
Cell Death Differ; 2001 May; 8(5):477-85. PubMed ID: 11423908
[TBL] [Abstract][Full Text] [Related]
71. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines.
Nagy L; Thomázy VA; Shipley GL; Fésüs L; Lamph W; Heyman RA; Chandraratna RA; Davies PJ
Mol Cell Biol; 1995 Jul; 15(7):3540-51. PubMed ID: 7791761
[TBL] [Abstract][Full Text] [Related]
72. Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells.
Lee HY; Dawson MI; Walsh GL; Nesbitt JC; Eckert RL; Fuchs E; Hong WK; Lotan R; Kurie JM
Cell Growth Differ; 1996 Aug; 7(8):997-1004. PubMed ID: 8853895
[TBL] [Abstract][Full Text] [Related]
73. Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines.
Li Y; Lin B; Agadir A; Liu R; Dawson MI; Reed JC; Fontana JA; Bost F; Hobbs PD; Zheng Y; Chen GQ; Shroot B; Mercola D; Zhang XK
Mol Cell Biol; 1998 Aug; 18(8):4719-31. PubMed ID: 9671482
[TBL] [Abstract][Full Text] [Related]
74. Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity.
Dawson MI; Hobbs PD; Peterson VJ; Leid M; Lange CW; Feng KC; Chen Gq ; Gu J; Li H; Kolluri SK; Zhang Xk ; Zhang Y; Fontana JA
Cancer Res; 2001 Jun; 61(12):4723-30. PubMed ID: 11406543
[TBL] [Abstract][Full Text] [Related]
75. Synthetic retinoid CD437 induces mitochondria-mediated apoptosis in hepatocellular carcinoma cells.
Gonda K; Tsuchiya H; Sakabe T; Akechi Y; Ikeda R; Nishio R; Terabayashi K; Ishii K; Matsumi Y; Ashla AA; Okamoto H; Takubo K; Matsuoka S; Watanabe Y; Hoshikawa Y; Kurimasa A; Shiota G
Biochem Biophys Res Commun; 2008 Jun; 370(4):629-33. PubMed ID: 18406343
[TBL] [Abstract][Full Text] [Related]
76. Identification of a unique binding protein specific for a novel retinoid inducing cellular apoptosis.
Fontana JA; Dawson MI; Leid M; Rishi AK; Zhang Y; Hsu CA; Lu JS; Peterson VJ; Jong L; Hobbs P; Chao WR; Shroot B; Reichert U
Int J Cancer; 2000 May; 86(4):474-9. PubMed ID: 10797258
[TBL] [Abstract][Full Text] [Related]
77. Synthetic retinoid CD437 induces apoptosis of esophageal squamous HET-1A cells through the caspase-3-dependent pathway.
Wan X; Duncan MD; Nass P; Harmon JW
Anticancer Res; 2001; 21(4A):2657-63. PubMed ID: 11724335
[TBL] [Abstract][Full Text] [Related]
78. Characterization of the differential coregulator binding signatures of the Retinoic Acid Receptor subtypes upon (ant)agonist action.
Miro Estruch I; Melchers D; Houtman R; de Haan LHJ; Groten JP; Louisse J; Rietjens IMCM
Biochim Biophys Acta Proteins Proteom; 2017 Sep; 1865(9):1195-1206. PubMed ID: 28642153
[TBL] [Abstract][Full Text] [Related]
79. Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid.
Ponzanelli I; Giannì M; Giavazzi R; Garofalo A; Nicoletti I; Reichert U; Erba E; Rambaldi A; Terao M; Garattini E
Blood; 2000 Apr; 95(8):2672-82. PubMed ID: 10753850
[TBL] [Abstract][Full Text] [Related]
80. Novel retinoic acid receptor alpha agonists for treatment of kidney disease.
Zhong Y; Wu Y; Liu R; Li Z; Chen Y; Evans T; Chuang P; Das B; He JC
PLoS One; 2011; 6(11):e27945. PubMed ID: 22125642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
